Genetically engineering a treatment for incurable brain tumors Purdue researchers are developing and validating a patent-pending treatment for incurable glioblastoma brain tumors. Glioblastomas are almost always lethal with a median survival time of 14 months. Traditional methods used against… more
Cover Art Selected by SmallYoon Yeo, Lillian Barboul Thomas professor of industrial and molecular pharmaceutics and biomedical engineering, recently had a cover art design selected for publication by scientific journal Small. The art appears in the publication’s inside back cover and accompanies… more
Excellent research Dr. Yeo!
Elizabeth Topp, a professor in the Department of Industrial and Molecular Pharmaceutics is using her expertise in chemistry to improve the shelf life and stability of pharmaceuticals
Title: synNotch-programmed iPSC-derived NK cells usurp TIGIT and CD73 activities for glioblastoma therapyAuthors: Lupo KB, Yao X, Borde S, Wang J, Torregrosa-Allen S, Elzey BD, Utturkar S, Attalah Lanman N, McIntosh M., Matosevic S.Journal/Publisher: Nature CommunicationsSummary (one paragraph that… more
New Young Institute Advisory Council to bolster Purdue pharmaceutical manufacturing
Recently, Professor Tony Zhou from IMPH received a third R01 grant from NIH to support his world-leading research program in developing novel inhalation therapeutics fighting notorious antimicrobial resistance. Antimicrobial resistance is one of the greatest threats to human health. Gram-… more
January newly issued patentsYoon Yeo, College of Pharmacy“Process and Composition Matter of Nanoparticle Formulation for Systemic Treatment of Sepsis”
Congratulations Dr. Park! IMPH is proud of you and your work. Seven Purdue University researchers were named in Clarivate’s 2023 list of Highly Cited Researchers, an indication of research excellence and influence. Clarivate’s report draws on data from the analytics company’s Web of Science… more
The Purdue College of Pharmacy honors and recognizes the outstanding research and scholarship generated by our faculty. This publication highlight recognizes Dr. Rodolfo Pinal, for the recent publication, "Tunable Drug Release Rate Using Modular Oral Dosage Forms" which can be read in … more